Literature DB >> 7918819

A case-control study of mesothelioma and employment in the Hawaii sugarcane industry.

T Sinks1, M T Goodman, L N Kolonel, B Anderson.   

Abstract

We conducted a case-control study of 93 mesothelioma cases and 281 cancer controls to determine whether sugarcane workers exposed to biogenic silica fibers were at increased risk of mesothelioma. We found no important excess risk of mesothelioma in sugarcane workers [odds ratio (OR) = 1.3; 95% confidence interval (CI) = 0.4-3.8] when we excluded all control subjects with cancer of sites suspected of being associated with asbestos exposure. We could not identify any sugarcane workers who developed mesothelioma and worked in jobs where high exposure levels of biogenic silica fibers have been measured. We did confirm that mesothelioma risk in Hawaii is associated with probable occupational asbestos exposure. Work at the Pearl Harbor Naval Shipyard was associated with a 10-fold increase in mesothelioma when we excluded controls with cancer of sites related to asbestos exposure (OR = 10.1; 95% CI = 2.6-56.6). Work in the medical industry was also associated with an unexpected increased risk for mesothelioma (OR = 4.2; 95% CI = 1.2-15.5).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7918819     DOI: 10.1097/00001648-199407000-00015

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  3 in total

1.  Case-control study of lung cancer among sugar cane farmers in India.

Authors:  D K Amre; C Infante-Rivard; A Dufresne; P M Durgawale; P Ernst
Journal:  Occup Environ Med       Date:  1999-08       Impact factor: 4.402

2.  IARC reevaluates silica and related substances.

Authors:  J D Wilbourn; D B McGregor; C Partensky; J M Rice
Journal:  Environ Health Perspect       Date:  1997-07       Impact factor: 9.031

3.  A pilot field evaluation on heat stress in sugarcane workers in Costa Rica: What to do next?

Authors:  Jennifer Crowe; Berna van Wendel de Joode; Catharina Wesseling
Journal:  Glob Health Action       Date:  2009-11-11       Impact factor: 2.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.